Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Squalamine Lactate Plus Carboplatin in Ovarian Cancer
NCT00021385Phase 2Unknown
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- May 2001
- Modality
- Multivalent & Scaffold-Based Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of squalamine in ovarian cancer, sponsored by UCLA Jonsson Comprehensive Cancer Center. Primary endpoints: Objective Response Rate, Time to Progression and 1 more. Status: unknown.
02
Drugs
squalamine
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00021385.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00021385.